ImaRx Therapeutics (Urokinase Business)
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Manufacturer of bio pharmaceutical products. The company manufactures thrombolytic which is used in treatment of acute massive pulmonary embolism.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 6860 Lexington Avenue
- Suite 120
- Los Angeles, CA 90038
- United States
ImaRx Therapeutics (Urokinase Business) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore ImaRx Therapeutics (Urokinase Business)‘s full profile, request access.
Request full access to PitchBookImaRx Therapeutics (Urokinase Business) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore ImaRx Therapeutics (Urokinase Business)‘s full profile, request access.
Request full access to PitchBook